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OBJECTIVES The goal of this study was to determine the relationship between repolarization and
excitability in the human atrium under various conditions.
BACKGROUND Action potential duration (APD) measurements from monophasic action potential (MAP)
recordings provide a surrogate for measuring the effective refractory period (ERP) in human
ventricle. The relationship between repolarization and refractoriness in human atrium and the
effect of prior atrial fibrillation/flutter on the ERP/APD correlation are unknown.
METHODS Seven patients with sinus rhythm and 15 patients after conversion of atrial flutter or
fibrillation were evaluated. Monophasic action potentials were recorded at multiple right atrial
sites and during different basic cycle lengths from 300 to 700 ms, while ERPs were
determined by extrastimulus technique using the MAP recording-pacing combination
catheter.
RESULTS There was a close correlation between ERP and APD at 70% repolarization (APD70, r 5
0.97; p , 0.001) and 90% repolarization (APD90, r 5 0.98; p , 0.001), respectively.
Refractoriness occurred at a repolarization level of 72 6 8%. The ERP/APD70 and
ERP/APD90 ratios averaged 1.06 6 0.10 and 0.86 6 0.08, respectively. These ratios were
nearly constant over the entire range of basic cycle lengths, between different sites in
individual patients and between different patients. Patients cardioverted from atrial fibrillation
or flutter exhibited no significant differences in the ERP/APD relationship compared with
patients with sinus rhythm.
CONCLUSIONS Effective refractory period and APD are closely related in the human right atrium. Using the
MAP recording technique, atrial ERPs can be assessed by measurement of APDs. Effective
refractory period is most closely reflected by APD70. Thus, MAP recordings allow
investigation of the local activation and repolarization time course beat by beat, visualizing the
excitable gap. (J Am Coll Cardiol 2001;37:920–5) © 2001 by the American College of
Cardiology
Myocardial cells regain excitability as repolarization
progresses—in both a voltage-dependent and time-
dependent manner (1). Therefore, a relatively close relation-
ship can be expected to exist between the duration of
repolarization (or the action potential duration [APD]) and
the duration of the effective refractory period (ERP). Pre-
vious in vitro studies using microelectrode technique (2,3)
and in vivo studies using the monophasic action potential
(MAP) recording technique (4,5) have shown that, in
ventricular myocardium, ERP ends when the action poten-
tial repolarizes to the 75% to 85% level (6–9). Myocardial
disease or antiarrhythmic drug treatment (primarily with
sodium-channel blocking agents) may change this relation-
ship by causing postrepolarization refractoriness (3,4,8,10).
Yet, under normal conditions, ventricular APD can be
regarded as a surrogate for ERP.
In atrial myocardium, the relationship between ERP and
APD has not been sufficiently evaluated. Little is known
about the direct relationship of atrial ERP and APD at
different cycle lengths (11), and no data exist for the human
in situ heart.
This study set out to determine the relationship between
APD and ERP in the human atrial myocardium in vivo. Our
study was prompted by the following considerations. If a
similar correspondence and stability of the ERP/APD ratio
could be found in the atrium, as was previously established for
the ventricle, several purposes would be served: 1) Atrial ERPs
could be assessed directly by measuring atrial APDs (using the
MAP technique) during atrial electrophysiological interroga-
tions; 2) these assessments would be valid at any given
spontaneous or paced cycle length or recording site; 3) APD,
rather than ERP, measurements would suffice to determine the
spatial and temporal dispersion of atrial refractoriness without
the need for interrupting the prevailing cycle length by re-
peated extrastimuli, which are bound to perturb the steady
state; and 4) it would allow the distinction between the
approximate end of refractoriness and the following depolar-
ization during spontaneous atrial tachyarrhythmias, thus allow-
ing the electrophysiologist direct visualization of the excitable
gap (12,13).
METHODS
Patients. Measurements were performed in 22 patients (21
men and 1 woman) aged 24 to 80 years (mean 65 6 13).
Seven patients underwent routine electrophysiological stud-
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ies for evaluation of syncope or nonsustained ventricular
tachycardia. Twelve patients were studied 10 min after
cardioversion of atrial fibrillation (n 5 6) or flutter (n 5 6).
Three patients were investigated 30 min after atrial flutter
ablation. Demographic and clinical data of the patient
population are summarized in Table 1. All patients gave
written informed consent to the protocol that had been
approved by the institutional ethics review board. Antiar-
rhythmic drugs had been discontinued for at least 5 half-
lives before the study.
Electrophysiological study. A monophasic action poten-
tial recording/pacing combination catheter (6) (EP Tech-
nologies Inc., San Jose, California) was introduced via a
femoral vein and positioned in the right atrium. The
catheter position was documented by fluoroscopy in right
anterior oblique and left anterior oblique projection.
Monophasic action potentials and surface electrocardiogram
leads were recorded on a BARD computer system. Pacing
and MAP recording were performed simultaneously at the
same endocardial site. Continuous overdrive pacing at 23
diastolic threshold strength and a basic drive cycle length of
600 ms was performed for 2 min before each recording to
establish steady state. After a train of eight stimuli (S1), an
extrastimulus (S2) was introduced during the diastolic in-
terval. With each train, the S1-S2 coupling interval was
decreased in steps of 5 ms until the ERP was reached,
defined by the longest S1-S2 interval that failed to induce a
propagated response (Fig. 1). The pause between drive
trains was 2 s.
Abbreviations and Acronyms
APD 5 action potential duration
APD705 action potential duration at 70% repolarization
APD905 action potential duration at 90% repolarization
ERP 5 effective refractory period
MAP 5 monophasic action potential
Table 1. Selected Clinical and Electrophysiologic Features of Study Patients*
Age
(yrs)
Arrhythmia
Diagnosis
LA Size
(mm)
LVEF
(%)
Afib/flut
Duration
(months)
Conversion
Mode
Control Patients
77 syncope 42 67
49 nsVT 39 30
65 syncope 37 60
24 syncope 30 58
73 nsVT 47 40
55 syncope 41 73
80 syncope 45 45
Mean 60.4 40.1 53.3
SD 19.7 5.6 15.4
Patients With Aflut
78 typical 40 50 2 DC shock
52 typical 52 30 N/A pace out
67 typical 43 55 0.75 DC shock
64 atypical 44 55 18 pace out
74 typical 48 50 1.5 pace out
80 typical 43 35 2 pace out
64 typical 42 35 20 ablation
77 atypical 45 45 1 ablation
51 typical 45 20 7 ablation
Mean 67.4 44.7 41.7 7.4
SD 10.8 3.5 12.2 8.2
Patients With Afib
67 59 55 5 DC shock
58 48 35 28 DC shock
74 51 55 0.75 DC shock
77 49 60 26 DC shock
65 48 25 2 DC shock
62 41 55 1 DC shock
Mean 67.2 49.3 47.5 10.5
SD 7.2 5.8 14.1 12.9
*Mean age, LA size and LVEF were not significantly different between groups.
Afib 5 atrial fibrillation; Aflut 5 atrial flutter; DC 5 direct current; LA 5 left atrial; LVEF 5 left ventricular ejection
fraction; N/A 5 not applicable; nsVT 5 nonsignificant ventricular tachycardia; pace out 5 termination of atrial flutter by
overdrive pacing.
921JACC Vol. 37, No. 3, 2001 Bode et al.
March 1, 2001:920–5 ERP/APD in Human Atria
To determine whether the relation between repolariza-
tion and refractoriness varies between different atrial sites,
the catheter was repositioned to at least one other right
atrial site in each patient, and the protocol was repeated.
Recordings were obtained from the high right atrium,
anterior/appendage locations, midseptal and posterior sites,
lateral free wall and low right atrium.
In nine patients, extrastimulation was performed at basic
cycle lengths of 700 ms, 600 ms, 500 ms, 400 ms and
300 ms at the same atrial site to investigate the effect of cycle
length changes on the ERP/APD relation.
Data analysis. The following variables were analyzed: 1)
MAP duration at 70% repolarization (APD70) and 2) at
90% repolarization (APD90), 3) ERP and 4) the repolariza-
tion level at which refractoriness occurred (Fig. 1). The
ratios between ERP and APD70 and between ERP and
APD90 were calculated.
Statistics. Data are presented as mean 6 standard devia-
tion. Two-way analysis of variance for mixed effects was
used to test differences in ERP, APD and ERP/APD ratios
between various sites and cycle lengths with post hoc
analysis by Bonferroni. Sites or cycle lengths contributed
fixed effects, while single patients contributed random
effects. Group dependent differences were evaluated by
one-way repeated-measures analysis of variance using a
mixed model. Correlations between ERP and APD were
evaluated by linear regression analysis. A p , 0.05 defined
statistical significance.
RESULTS
Stable MAP recordings were obtained in all patients. The
average diastolic pacing threshold through the MAP com-
bination catheter was 0.4 6 0.2 mA.
ERP/APD ratio at different sites. At a basic cycle length
of 600 ms, APD and ERP were determined at two to six
different sites in each patient (average 2.8 sites). A large
dispersion of APD90 was found between similar atrial
locations in different patients (80 6 12 ms) and between
different atrial sites in an individual patient (39 6 18 ms).
The dispersion of ERP averaged 59 6 13 ms between
similar locations in different patients and 34 6 17 ms
between different atrial sites in an individual patient. De-
spite this dispersion, there was a close relation between
APD and ERP because the intra- and interindividual
repolarization levels at which refractoriness occurred were
fairly identical. On average, the ERP occurred at 72 6 9%
repolarization of the preceding action potential. The rela-
tionship between APD and ERP is commonly expressed by
the ERP/APD ratio. The overall ERP/APD90 ratio was
0.86 6 0.08; the overall ERP/APD70 ratio was 1.06 6 0.10.
The ERP/APD ratios showed no appreciable difference
between various right atrial sites (Fig. 2).
ERP/APD ratio at different steady-state cycle lengths. A
decrease in basic cycle length from 700 ms to 300 ms
shortened APD90 from 285 6 26 ms to 232 6 23 ms (p ,
0.001) and APD70 from 233 6 19 ms to 188 6 19 ms (p ,
0.001). In parallel, ERP shortened from 247 6 20 ms to
197 6 20 ms (p , 0.001). Linear regression analysis of 12
paired recordings at different right atrial sites and different
basic cycle lengths in nine patients revealed that APD and
ERP were highly correlated (r 5 0.85 both for APD90 and
APD70; p , 0.001, Fig. 3). When recordings from a single
site were evaluated over different basic cycle lengths, the
correlation between APD and ERP was even more stringent
(average correlation of paired data sets: r 5 0.98 for APD90;
p , 0.001 and r 5 0.97 for APD70; p , 0.001). Conse-
Figure 1. Simultaneous measurement of effective refractory period (ERP)
and action potential duration at 70% repolarization (APD70) and 90%
repolarization (APD90) with the combination catheter. S1 and S2 denote
the basic and extrastimulus artifacts. Repolarization levels (n%) at which
extrastimuli are superimposed onto the preceding repolarization phase are
visualized.
Figure 2. Ratio between effective refractory period (ERP) and action
potential duration at 70% (APD70) and 90% repolarization (APD90) at
different right atrial sites. Ratios exhibited no significant site-specific
differences.
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quently, the ERP/APD90 and ERP/APD70 ratios remained
nearly constant during a stepwise decrease in cycle length
(Fig. 4).
ERP/APD ratio in patients with prior atrial fibrillation
or flutter. Patients cardioverted from atrial fibrillation or
atrial flutter tended to have slightly shorter APD and ERP
than control patients despite the same paced cycle length.
The ERP/APD ratios, however, did not differ between
patient groups, indicating that the repolarization level at
which refractoriness occurred was not influenced by the
prior existence of an atrial arrhythmia (Table 2).
DISCUSSION
This study shows a close relationship between repolarization
and refractoriness in the human right atrium. The relation-
ship was found to be highly constant between different atrial
sites and over a wide range of atrial cycle lengths. It was not
influenced by a prior atrial arrhythmia.
Unlike conventional clinical pacing and recording tech-
niques, the MAP recording/pacing catheter allowed stimu-
lation and recording at nearby myocardial sites. Due to the
short distance (,2 mm) between the distal pacing electrode
pair and the proximal recording electrode pair, local elec-
trical responses could be obtained with a minimum of
distant electrical activity. Stimulus artifacts were minimized
by low stimulus thresholds and did not interfere with
simultaneously recorded action potentials (6,14,15). The
repolarization time course could, therefore, be analyzed
precisely in the immediate vicinity of the pacing site.
Atrial ERP/APD ratio. Compared with action potentials
recorded from ventricular myocardium, atrial action poten-
tials are more triangular in shape because of a shorter phase
2 and a decreased slope of phase 3 (14,16). In the human
ventricle, refractoriness occurs at approximately 85% repo-
larization with stimuli of twice diastolic threshold strength
(5); while in the atrium, it occurred at approximately 72%
repolarization. Regardless of these differences, which might
be explained by different ion current distributions in atrial
and ventricular cells, our study confirmed the close correla-
tion of APD and ERP in the right atrium that has
previously been demonstrated in ventricular myocardium
using microelectrode (2,3) or MAP recording techniques
(7,8). Action potential durations at 90% and 70% repolar-
ization were similarly correlated to the ERP, showing that
both indexes of the repolarization time course can be
employed to express the relationship between repolarization
and refractoriness in the human right atrium. Because
refractoriness was found to occur at about 72% repolariza-
tion, APD70 reflected the ERP more closely than APD90.
Therefore, APD70 appears to be the more accurate index for
estimation of the right atrial ERP in drug-free myocardium.
Antiarrythmic drugs, especially class I, may change the
ERP/APD ratio to higher values, as was previously shown
for the human ventricle (3,4,8,10).
Site independence of the ERP/APD ratio. Our study
found a considerable dispersion of repolarization and refrac-
toriness between various atrial sites at a fixed cycle length.
Substantial site to site differences in APD and ERP are
Figure 3. (A) Correlation between effective refractory period (ERP) and
action potential duration at 70% repolarization (APD70) and (B) between
ERP and action potential duration at 90% repolarization (APD90).
Measurements were obtained at 12 different right atrial sites and different
steady state cycle lengths in nine patients.
Figure 4. Ratio between effective refractory period (ERP) and action
potential duration at 70% (APD70) and 90% repolarization (APD90) as a
function of basic cycle length (BCL). Ratios showed no significant cycle
length-dependent changes.
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known to occur even between adjacent myocardial locations
(17–20). Possible mechanisms underlying nonuniform re-
polarization and refractoriness between different myocardial
areas are inhomogeneous distribution of ion channels and
cardiac “memory” (21–23). However, these intersite differ-
ences in atrial repolarization did not lead to appreciable
changes in the average atrial ERP/APD ratio between sites,
indicating that changes in local refractoriness are always
closely related to repolarization despite site-specific varia-
tions in APD. The correlation between APD and ERP was
highly significant for different myocardial sites and even
more stringent at a single site. The difference might be
explained by slightly different action potential configura-
tions between sites, particularly the phase 3 repolarization
time course. Action potentials might be more triangular at
one site and more dome-shaped at another site, which can
create certain variations in the calculated ERP/APD ratios
between sites. At a given site, the slope of phase 3 and,
consequently, the ERP/APD ratio were constant, even if
APD changed during adaptation to a new cycle length.
Cycle-length independence of the ERP/APD ratio. In
ventricular myocardium, changes in APD due to alterations
in cycle length are paralleled by concurrent changes in ERP
(7–9). Our study confirmed at the atrial level that the cycle
length dependence of repolarization and refractoriness,
likewise, are closely interrelated. For the same slope-related
reasons (see previous text), the average ERP/APD ratio for
different atrial cycle lengths shows a standard deviation that
is explained by small intersite differences in the ERP/APD
ratio rather than cycle-length dependent variations in the
ratio at a given site.
Implications. The MAP recordings of the atrial repolar-
ization time course allow the clinical investigator to estimate
local refractoriness over a wide range of atrial rates. This
might be particularly helpful during sudden rate changes
where refractory period determinations are impractical, yet
MAP recordings display the repolarization time course on a
beat-to-beat basis. Therefore, estimations of atrial refracto-
riness by MAP recordings are feasible even in the presence
of continuous cycle length changes due to atrial arrhyth-
mias.
The atria of patients with atrial fibrillation or flutter have
been shown to undergo persistent electrophysiological
changes due to the presence of the arrhythmia, termed
electrical remodeling (24). A shortening of ERP (25) and
APD (26) and a loss of physiological rate adaptation of the
APD was noted, particularly at longer cycle lengths (26).
This study found small differences in APD and ERP
between control patients and patients cardioverted from
atrial fibrillation or flutter but no significant differences in
the ERP/APD relationship. This suggests that atrial re-
modeling does not affect the close relation between myo-
cardial repolarization and refractoriness, allowing accurate
estimation of local refractoriness by MAP recording in
patients with prior atrial tachyarrhythmias. As was already
suggested by previous studies, MAP recordings may allow
continuous monitoring of APD and estimation of ERP
even during atrial fibrillation or flutter, thereby allowing one
to directly visualize the excitable gap between repolarization
and the subsequent depolarization (12,13).
Conclusions. For the human right atrium, we documented
a close correlation between repolarization and the recovery
of excitability, with no significant effects on this relationship
by cycle length, recording site or prior tachyarrhythmias.
These first in vivo data of the human atrial ERP/APD
relationship provide validation of using APD measurements
from MAP recordings as a surrogate for ERP determina-
tions.
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